tiprankstipranks
AEON Biopharma (AEON)
:AEON
US Market

AEON Biopharma (AEON) Financial Statements

Compare
154 Followers

AEON Biopharma Financial Overview

AEON Biopharma's market cap is currently $8.58M. The company's EPS TTM is $-0.241; its P/E ratio is ―; AEON Biopharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Dec 21Dec 20Dec 19
Income Statement
Total Revenue$ 0.00$ 0.00$ 2.52M$ 3.36M
Gross Profit$ 0.00$ 0.00$ 2.52M$ 3.36M
Operating Income$ -48.43M$ -65.85M$ -16.39M$ -53.97M
EBITDA$ -48.36M$ -7.91M$ -22.14M$ -50.41M
Net Income$ -52.56M$ -55.64M$ -32.91M$ 172.92M
Balance Sheet
Cash & Short-Term Investments$ 9.75M$ 5.13M$ 20.17M$ 111.75M
Total Assets$ 10.78M$ 6.44M$ 21.21M$ 114.35M
Total Debt$ 131.53M$ 86.89M$ 72.16M$ 29.95M
Net Debt$ 121.79M$ 81.76M$ 51.99M$ 23.63M
Total Liabilities$ 281.19M$ 230.26M$ 224.45M$ 180.22M
Stockholders' Equity$ -287.50M$ -234.94M$ -208.27M$ -67.15M
Cash Flow
Free Cash Flow$ -35.89M$ -28.60M$ -9.46M$ -46.42M
Operating Cash Flow$ -35.58M$ -28.43M$ -9.46M$ -44.73M
Investing Cash Flow$ -306.00K$ -170.00K$ -1.26M$ -117.29M
Financing Cash Flow$ 40.51M$ 13.56M$ 24.57M$ 73.21M
Currency in USD

AEON Biopharma Earnings and Revenue History

AEON Biopharma Debt to Assets

AEON Biopharma Cash Flow

AEON Biopharma Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis